Zobrazeno 1 - 10
of 276
pro vyhledávání: '"Y Barbier"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
E. Etéchami, Stéphanie Gutton, Emilie Labbe, X. Pagnon, Michel Pouchard, S. Lazarus, Bienvenu Bongue, Y. Barbier, Laurent Gerbaud, P. Laboulaye, K. Soufi, J-J Moulin, Catherine Sass, C. Nitenberg, M. Depierre, Carine Chatain, B. Léger, D. Philippe, C De La Celle, M.-P. Vandernoot, H Le Clésiau, J-L Lenain, J.-F. Rohmer
Publikováno v:
Pratiques et Organisation des Soins. 42:79-87
Objectifs : Les centres d’examens de sante de l’Assurance maladie doivent contribuer a favoriser l’insertion des personnes socialement vulnerables dans le systeme de soins. Cette enquete avait pour objectif de documenter les suites donnees a l
Publikováno v:
Bulletin of Entomological Research. 99:337-346
There is a severe shortage of knowledge of bee biogeography. Some former studies have highlighted a link between bee diversity and xeric ecosystems, but we know practically nothing of the macro-ecological factors driving bee diversity. The present st
Autor:
F. Chapuis, A Fond, N. Stremsdoerfer, P.J. Valette, Y. Barbier, Jessika Moreau, H Moindrot, F Hedelius, J.L. Gaudin, C. Lombard-Bohas, R. Mackiewicz, M.C. Gouttebel, F Desseigne, M.O. Heilmann, A Moraillon, P Kaemmerlen, V. Trillet-Lenoir, O Pellet, L. Chassignol, G. Lledo, J.D. Boyer, G. Freyer, J.P. Bleuse
Publikováno v:
The British Journal of Radiology. 75:903-908
Evaluation of tumour size modifications in response to treatment is a critical issue in the management of advanced malignancies. In 1981, the World Health Organization (WHO) established guidelines for tumour response assessment. These WHO1981 criteri
Autor:
A Mayer, Catherine Thieblemont, Françoise Berger, Bertrand Coiffier, C Martin, Gilles Salles, Pascale Felman, Evelyne Callet-Bauchu, Charles Dumontet, Y. Barbier, J Orgiazzi, X Ducottet
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism. 87:105-111
We retrospectively analyzed 26 patients with thyroid lymphoma (TL). Patients were mostly females, with a median age of 59 yr, presenting a rapidly growing nodular goiter with or without cervical adenopathy, without symptoms related to lymphoma for 81
Autor:
F Chossat, J Tebib, J P Wargnies, A Kahan, J Y Devaux, L Lebègue, M. Di Paola, B. Aubert, P Verrier, P Voisin, Y Barbier, C J Menkes, L Manil, D Guerreau
Publikováno v:
Nuclear Medicine Communications. 22:405-416
Physical and biological dosimetry were investigated in 45 rheumatoid arthritis patients treated by radiosynoviorthesis (RSO) with 186Re-sulphide (medium-sized joints) and 169Er-citrate (digital joints). Biological dosimetry involved scoring dicentric
Publikováno v:
Pathophysiology of Haemostasis and Thrombosis. 24:36-48
This study explored the relationship between cytokines (TNF, IL-1, IL-6), coagulation and fibrinolytic factors in the early stage of sepsis syndrome and the relation between these factors with the severity of inflammatory illness as measured by the S
Autor:
François-Noël Gilly, J. Bienvenu, G. Braillon, Y. Barbier, P. Y. Carry, M. C. Gutowski, M. Barbier, L. Coulon, G. Panteix, A. C. Sayag
Publikováno v:
Oncology. 50:371-374
The aim of the present work is to investigate in vivo cytokine production during chemohyperthermia. 11 patients suffering from gastric adenocarcinoma (n = 6), ovarian adenocarcinoma (n = 4) or malignant mesothelioma (n = 1) were studied. Patients rec
Publikováno v:
Clinical Rheumatology. 11:502-507
The level of the N terminal fragment of procollagen III (P3NP) levels of 100 consecutive patients affected by rheumatoid arthritis (RA) were evaluated in comparison with disease activity markers (erythrocytes sedimentation rate, C reactive protein),
Autor:
S. Borzakian, Y. Barbier, Florence Colbère-Garapin, G. Attal, Isabelle Pelletier, Thérèse Couderc
Publikováno v:
Virology
Virology, Elsevier, 1992, 186 (2), pp.398-408
Virology, 1992, 186 (2), pp.398-408
Virology, Elsevier, 1992, 186 (2), pp.398-408
Virology, 1992, 186 (2), pp.398-408
Mutants of poliovirus (PV) with highly modified biological properties can be selected in vitro in cells of neural origin. Mutations accumulate in the genome of type 1 PV strains selected in human neuroblastoma cells, modifying cell specificity and co